Jan 11, 2022 / 03:30PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Hey, good morning everybody. I'm Tycho Peterson from Life Science Team. It's my pleasure to introduce our next company this morning, Charles River Laboratories. Just a quick reminder, if you have questions submit them through the website, and with that I will turn it over to Jim.
James C. Foster - Charles River Laboratories International, Inc. - Chairman, CEO & President
Thank you Tycho, always a pleasure to be at JPMorgan Conference albeit virtually. Should take notice of our Safe Harbor, Reg G and quiet period disclaimer. So we worked on 85% of all the drugs that were approved by FDA last year. Actually 100% of the CNS drugs and 92% of the oncology drugs. We're obviously very proud of those statistics and very proud of the role that we play in the drug development paradigm. We have doubled the size of Charles River over the last 5 years, and we're proud of that as well. We have the #1 position in most of the businesses that we're in, and we have a market in which we are
Charles River Laboratories International Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers